NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.5650
+0.0763 (15.61%)
At close: Aug 14, 2026, 4:00 PM EDT
0.5792
+0.0142 (2.51%)
Pre-market: Aug 17, 2026, 5:03 AM EDT
NEXGEL Revenue
NEXGEL had revenue of $2.65M in the quarter ending March 31, 2026, a decrease of -5.56%. This brings the company's revenue in the last twelve months to $11.26M, up 10.14% year-over-year. In the year 2025, NEXGEL had annual revenue of $11.42M with 31.46% growth.
Revenue (ttm)
$11.26M
Revenue Growth
+10.14%
P/S Ratio
0.46
Revenue / Employee
$592,895
Employees
19
Market Cap
5.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.42M | 2.73M | 31.46% |
| Dec 31, 2024 | 8.69M | 4.60M | 112.47% |
| Dec 31, 2023 | 4.09M | 2.04M | 99.66% |
| Dec 31, 2022 | 2.05M | 497.00K | 32.04% |
| Dec 31, 2021 | 1.55M | 877.00K | 130.12% |
| Dec 31, 2020 | 674.00K | -43.00K | -6.00% |
| Dec 31, 2019 | 717.00K | -1.50M | -67.60% |
| Dec 31, 2018 | 2.21M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.81M |
| Retractable Technologies | 37.15M |
| Bionano Genomics | 30.18M |
| Precision Optics Corporation | 28.94M |
| Nephros | 20.72M |
| Jin Medical International | 19.73M |
| Milestone Scientific | 9.42M |
| Lucyd | 2.98M |
NXGL News
- 2 days ago - NEXGEL Proxy statement: Proxy filing - Filings
- 7 weeks ago - NEXGEL Slides: Investor presentation - Filings
- 2 months ago - NEXGEL Transcript: Planet MicroCap Las Vegas 2026 - Transcripts
- 2 months ago - NEXGEL Proxy statement: Proxy filing - Filings
- 2 months ago - NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th - GlobeNewsWire
- 2 months ago - NEXGEL Proxy statement: Proxy filing - Filings
- 3 months ago - NexGel announces data from institutional review board clinical study - TheFly
- 3 months ago - NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration - GlobeNewsWire